Under construction – not a live service

Skip to content

Frontlight Research

Institution

RTI Health Solutions

Durham, United StatesWebsite

1closed trial
3,495publications (OpenAlex)

Closed trials

Completed
A Study to Evaluate Treatment Patterns, Outcomes, and Healthcare Resource Utilization in Patients With Lower-Risk Myelodysplastic Syndromes Treated With Luspatercept
NCT07075406· Bristol-Myers Squibb· Source

Registry name variants (1)

Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.

RTI Health Solutions
Research Triangle Park, North Carolina 27709-2194
1 trial
- NCT07075406A Study to Evaluate Treatment Patterns, Outcomes, and Healthcare Resource Utilization in Patients With Lower-Risk Myelodysplastic Syndromes Treated With Luspatercept

Conditions

Diseases this institution publishes on or runs trials for.

Alopecia areata4 works · 0 trials
Narcolepsy3 works · 0 trials

Institution data: ROR 032nh7f71 (CC0-1.0)Updated 12 Nov 2026

Report an error